Latest Capital Raise News

The Calmer Co. International Limited reported a 6% quarterly revenue increase to $1.9 million in Q4 FY25, driving FY25 revenue to $8.0 million, an 86% year-on-year growth. Key channel expansions and cost efficiencies underpin its progress towards breakeven.

Titanium Sands Limited has secured retention licenses for four critical exploration areas and is progressing its Environmental Impact Assessment in Sri Lanka, while engaging government officials and local landowners to navigate regulatory hurdles.

Golden Mile Resources has completed its first Reverse Circulation drilling campaign at the Pearl Copper Project in Arizona, revealing significant copper, lead, zinc, and silver mineralisation. Meanwhile, drilling continues at its Leonora Gold JV with assay results pending.

Lithium Universe Limited has secured global rights to a breakthrough solar panel recycling technology that promises to unlock vast reserves of critical minerals, while advancing its Québec lithium refinery with robust financials and strategic partnerships.

Amplia Therapeutics reports encouraging ACCENT trial results for its FAK inhibitor narmafotinib, including rare complete responses in pancreatic cancer, alongside a $27.5 million capital raise to fund ongoing clinical development.

Western Mines Group has announced a landmark Mineral Resource Estimate for its Mulga Tank project, defining Australia’s largest nickel sulphide deposit with over 5.3 million tonnes of contained nickel. The company has secured government grants and raised capital to accelerate drilling and metallurgical testing.

Cosmo Metals has raised $2 million through a strategic placement to fast-track exploration at its promising NSW gold, antimony, and copper projects, with maiden drilling set to begin this quarter.

Vection Technologies capped FY25 with its highest monthly order intake ever, driven by defence and AI/XR contracts, while posting positive pro-forma cash flow despite payment timing issues.

Fluence Corporation Limited reported a positive net operating cash flow of US$5.1 million for Q2 2025, boosting its cash reserves to US$12.7 million and maintaining solid liquidity through revolving credit and loan facilities.

Sunstone Metals reports promising exploration results from its Ecuadorian gold-copper projects alongside ongoing strategic discussions with multiple parties in a buoyant M&A environment.

Nyrada reports successful completion of five cohorts in its Phase I trial of Xolatryp with no safety concerns, alongside compelling preclinical neuro- and cardioprotective data. A Phase IIa trial targeting heart attack patients is slated for early 2026.

Harvest Technology Group reports a 135% revenue increase in Q4 FY25, new leadership appointments, and a strategic listing on the Frankfurt Stock Exchange to broaden its investor base.